Long-Term Use of Rivastigmine in Patients With Dementia With Lewy Bodies: An Open-Label Trial

No abstract is available for this paper.

• Publication year

  2001

• Venue

  International Psychogeriatrics

• Publication date

  2001-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S104161020100758XPMID 11495394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial

  2000cited by this paper
• Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

  2000cited by this paper
• Donepezil for dementia with Lewy bodies: a case study

  1999cited by this paper
• Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients

  1998cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.

  1994cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• The cholinergic system in dementia with Lewy bodies.

  2025cites this paper
• Rivastigmine for parkinsonian symptoms in dementia with Lewy bodies: a paradigm shift.

  2025cites this paper
• Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

  2025cites this paper
• Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12‐week multicentre, randomised, double‐blind, and placebo‐controlled phase IV study

  2024cites this paper
• Systematic review of pharmacological interventions for people with Lewy body dementia

  2022cites this paper
• Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease

  2021cites this paper
• Outcome Measures for Dementia With Lewy Body Clinical Trials

  2021cites this paper
• Psychopharmacologic treatment

  2020cites this paper
• Clinical drug development for dementia with Lewy bodies: past and present

  2019cites this paper
• Demência com corpos de Lewy

  2019cites this paper
• Use of Cholinesterase Inhibitors in Non-Alzheimer’s Dementias

  2019cites this paper
• Prevalence and Treatment of Constipation in Patients with Alpha-Synuclein Pathology

  2018cites this paper
• [The addition of memantine to galantamine increases treatment efficacy in patients with moderate dementia with Lewy bodies].

  2018cites this paper
• Donepezil for Constipation in Lewy Body Diseases: Four Case Studies

  2017cites this paper
• A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors.

  2017cites this paper
• Mechanisms of a-Synuclein Pathology and Treatment in the Enteric Nervous System

  2017cites this paper
• Diagnosis and management of dementia with Lewy bodies

  2017cites this paper
• Pharmacotherapy in dementia with lewy bodies

  2017cites this paper
• Rivastigmine: Dementia with Lewy Bodies

  2016cites this paper
• Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial.

  2016cites this paper
• Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled Trials

  2016cites this paper
• Synaptic pathology: A shared mechanism in neurological disease.

  2016cites this paper
• Dementia With Lew Body

  2016cites this paper
• Child and Adolescent Psychiatry.

  2015cites this paper
• Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

  2015cites this paper
• The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease

  2015cites this paper
• Exploring the role of donepezil in dementia with Lewy bodies.

  2015cites this paper
• Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies

  2015cites this paper
• Vers l'imagerie in vivo de l'alpha-synucléine.

  2015cites this paper
• Ethynylphenyl carbonates and carbamates as dual-action acetylcholinesterase inhibitors and anti-inflammatory agents.

  2015cites this paper
• Clinical features of dementia with lewy bodies in 35 Chinese patients

  2014cites this paper
• Dementia with Lewy Bodies

  2014cites this paper
• Maladie à corps de Lewy

  2014cites this paper
• Malattia a corpi di Lewy

  2014cites this paper
• Management of psychosis and dementia

  2013cites this paper
• Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

  2013cites this paper
• Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial

  2012cites this paper
• Dementia With Lewy Bodies

  2011cites this paper
• Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

  2011cites this paper
• Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology

  2011cites this paper
• A GUIDE TO THE MANAGEMENT OF PSYCHOTIC DISORDERS AND NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA IN OLDER ADULTS

  2011cites this paper
• Dementia with lewy bodies: diagnosis and management for primary care providers.

  2011cites this paper
• The Lewy Body Dementia Spectrum (Alpha Synucleinopathies)

  2010cites this paper
• Cholinesterase inhibitors: beyond Alzheimer’s disease

  2010cites this paper
• TOP CITED PAPERS IN INTERNATIONAL PSYCHOGERIATRICS: 1. LONG-TERM USE OF RIVASTIGMINE IN PATIENTS WITH DEMENTIA WITH LEWY BODIES: AN OPEN-LABEL TRIAL

  2009cites this paper
• ALZHEIMER'S DISEASE AND DEMENTIAS

  2009cites this paper
• International Psychogeriatrics comes of age

  2009cites this paper
• The Behavioral Neurology of Dementia: Dementia treatment

  2009cites this paper
• 不同材料神經導管中周邊神經再生情形及相關蛋白質表現評估;Evaluation of Regenerated Nerves and Their Protein Expression in Three Different Conduit Materials

  2009cites this paper
• 10 – La Démence à Corps de Lewy et les Autres Syndromes Parkinsoniens Associés à une Démence

  2008cites this paper
• Neuropsychiatric evaluation in dementia.

  2008cites this paper
• Clinical aspects of dementia with Lewy bodies.

  2008cites this paper
• A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders

  2008cites this paper
• [Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

  2008cites this paper
• Sommeil et démences. Particularités et prise en charge

  2008cites this paper
• [Hallucinations associated to treatment with rivastigmine in two patients with diffuse Lewy body disease].

  2007cites this paper
• DEMENCIA CON CUERPOS DE LEWY Y DEMENCIA DE LA ENFERMEDAD DE PARKINSON: Revisión Actualizada del Diagnóstico y Tratamiento

  2007cites this paper
• Lewy Body Disorders

  2007cites this paper
• Behandlung der Demenz bei Parkinson-Syndromen

  2007cites this paper
• Distinguishing Lewy body dementias from Alzheimer’s disease

  2007cites this paper
• Dementia with Lewy bodies.

  2007cites this paper
• The management of psychosis in movement disorder patients

  2007cites this paper
• Chapter 9 Dementia with Lewy Bodies and Parkinson's Disease Dementia

  2007cites this paper
• Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.

  2007cites this paper
• Cognitive and Psychopathologic Response to Rivastigmine in Dementia With Lewy Bodies Compared to Alzheimer’s Disease: A Case Control Study

  2007influential citation
• Treatment of Dementia in Parkinsonian Syndromes with Cholinesterase Inhibitors

  2007cites this paper
• Clinical Trials in Parkinson's Disease Dementia and Dementia with Lewy Bodies

  2007cites this paper
• Chapter 16 Behavioral Syndromes and Their Treatment

  2007cites this paper
• Dementia with Lewy bodies.

  2007cites this paper
• 以聚乳酸酯纖維編織而成的多孔性神經導管充填銀杏葉酯對截斷大鼠坐骨神經再生影響之評估;Evaluation of Porous Nerve Guide Conduits Filled with Bilobalide and Made of Braided Poly-lactic Acid

  2007cites this paper
• Prise en charge thérapeutique de la démence à corps de Lewy

  2006cites this paper
• Clinical practice with anti-dementia drugs: a consensus statement from British Association for

  2006cites this paper
• [The neurochemistry and neuropharmacology of diffuse Lewy body disease].

  2006cites this paper
• [Treatment of dementia with Lewy bodies].

  2006cites this paper
• Demenz bei Parkinson-Syndromen: Lewy-Körper-Demenz, idiopathisches und andere Parkinson-Syndrome, Normaldruckhydrozephalus

  2006influential citation
• Behavioral benefits of trazodone are sustained for the long term in frontotemporal dementia

  2006cites this paper
• Dementia with lewy bodies: therapeutic opportunities and pitfalls.

  2006cites this paper
• Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology

  2006cites this paper
• PD-related psychosis: pathophysiology with therapeutical strategies.

  2006cites this paper
• Progress in Neurotherapeutics and Neuropsychopharmacology: Rivastigmine in the treatment of dementia associated with Parkinson's disease: a randomized, double-blind, placebo-controlled study

  2006cites this paper
• Dementia with Lewy bodies.

  2006cites this paper
• Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology

  2006cites this paper
• Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.

  2005cites this paper
• LONG‐TERM PRACTICE OF JAQUES‐DALCROZE EURHYTHMICS PREVENTS AGE‐RELATED INCREASE OF GAIT VARIABILITY UNDER A DUAL TASK

  2005cites this paper
• PAROXETINE AND IMPROVEMENT OF VISUAL HALLUCINATIONS IN PATIENTS WITH DEMENTIA WITH LEWY BODIES

  2005cites this paper
• Update on dementia with lewy bodies

  2005cites this paper
• NONAGENARIANS AND TRAUMA: AN INCREASINGLY COMMON COMBINATION

  2005cites this paper
• A comparison of the efficacy of donepezil in Parkinson's disease with Dementia and Dementia with Lewy bodies

  2005cites this paper
• Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia

  2005cites this paper
• The neurochemical and behavioral effects of the novel cholinesterase–monoamine oxidase inhibitor, ladostigil, in response to L‐dopa and L‐tryptophan, in rats

  2005cites this paper
• NO POSITIVE CORRELATION BETWEEN ANEMIA AND DISABILITY IN OLDER PEOPLE IN JAPAN

  2005cites this paper
• Current and Future Therapeutic Approaches

  2005cites this paper
• Diagnosis of dementia with Lewy bodies in clinical practice: a literature review.

  2005cites this paper
• Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

  2005cites this paper
• Rivastigmine for Alzheimer’s disease

  2005cites this paper
• Clinical Diagnosis of Dementia With Lewy Bodies

  2005cites this paper
• Neurodegenerative Diseases: Dementia with Lewy bodies

  2005cites this paper
• Review Copy Not For Commercial use

  2005cites this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cites this paper
• Diagnosis of Dementia With Lewy Bodies in Clinical Practice: A Literature Review

  2005cites this paper